LT-NS001: Phase Ic start

This half, the company will begin a double-blind, international Phase Ic trial to evaluate 1,200 mg of oral LT-NS001 given twice daily or 500 mg of twice-daily Naprosyn naproxen for 7.5 days in 120 he...